Entry, Retention, and Virological Suppression in an HIV Cohort Study in India: Description of the Cascade of Care and Implications for Reducing HIV-Related Mortality in Low- and Middle-Income Countries.
about
Risk factors for delayed entrance into care after diagnosis among patients with late-stage HIV disease in southern VietnamMortality in HIV-infected patients with tuberculosis treated with streptomycin and a two-week intensified regimen: data from an HIV cohort study using inverse probability of treatment weightingDirectly-observed intermittent therapy versus unsupervised daily regimen during the intensive phase of antituberculosis therapy in HIV infected patientsMortality and Loss to Follow up Before Initiation of Antiretroviral Therapy Among HIV-Infected Children Eligible for HIV Treatment.Interventions to improve or facilitate linkage to or retention in pre-ART (HIV) care and initiation of ART in low- and middle-income settings--a systematic reviewIncidence and mortality of tuberculosis before and after initiation of antiretroviral therapy: an HIV cohort study in India.High levels of heterogeneity in the HIV cascade of care across different population subgroups in British Columbia, CanadaIntimacy versus isolation: a qualitative study of sexual practices among sexually active HIV-infected patients in HIV care in Brazil, Thailand, and Zambia.Adding Streptomycin to an Intensified Regimen for Tuberculous Meningitis Improves Survival in HIV-Infected Patients.Economic and epidemiological impact of early antiretroviral therapy initiation in India.HIV care continuum among men who have sex with men and persons who inject drugs in India: barriers to successful engagement.Building the evidence base for stigma and discrimination-reduction programming in Thailand: development of tools to measure healthcare stigma and discriminationThe need for standardisation of the HIV continuum of care.Seven year review of retention in HIV care and treatment in federal medical centre Ido-Ekiti.Optimal Duration of Daily Antituberculosis Therapy before Switching to DOTS Intermittent Therapy to Reduce Mortality in HIV Infected Patients: A Duration-Response Analysis Using Restricted Cubic Splines.Epidemiological impact of achieving UNAIDS 90-90-90 targets for HIV care in India: a modelling study.Predictors of loss to follow-up after engagement in care of HIV-infected children ineligible for antiretroviral therapy in an HIV cohort study in India.Description of the cascade of care and factors associated with attrition before and after initiating antiretroviral therapy of HIV infected children in a cohort study in IndiaFrom HIV infection to therapeutic response: a population-based longitudinal HIV cascade-of-care study in KwaZulu-Natal, South Africa.Prevalence and correlates of psychosocial conditions among people living with HIV in southern India.IAPAC Guidelines for Optimizing the HIV Care Continuum for Adults and Adolescents.Short-Course Induction Treatment with Intrathecal Amphotericin B Lipid Emulsion for HIV Infected Patients with Cryptococcal Meningitis.Evaluation of patient care cascade for HIV-positive patients diagnosed in La Romana, Dominican Republic in 2011: a retrospective cohort study.Pattern of linkage and retention in HIV care continuum among patients attending referral HIV care clinic in private sector in India.Regional Challenges in the Prevention of Human Immunodeficiency Virus Drug Resistance.Association between internalized stigma and depression among HIV-positive persons entering into care in Southern India.Clinical Benefits and Cost-Effectiveness of Laboratory Monitoring Strategies to Guide Antiretroviral Treatment Switching in India.ART initiation in an outpatient treatment center in Dakar, Senegal: A retrospective cohort analysis (1998-2015)
P2860
Q28543860-F98E5426-1A27-45A0-93AA-69D9F12C4026Q31102969-3E7ED845-E4CA-4ED7-B2F7-46F1D31C0F48Q33809970-47AD406F-8D4E-4991-89A7-3DB1D105B82EQ33851192-615E9129-88B1-43C0-B7B4-FF0CD1F10264Q34006969-3873A688-4D4B-4918-8090-F6D8E7EE2896Q34675209-07010C80-58D6-4C9F-A2FB-8C33EC3FD929Q34776035-653662C5-4BAD-4A62-88C4-FC6744BEA61DQ35202674-469749B1-4497-418F-AA24-16C77A7CBC38Q35963971-A564B640-5319-446E-93DD-20321EF49D3BQ36119499-1AC5C67E-1034-43C0-B3A8-CA5335B9D0C3Q36276201-EEE290E3-CB79-4DA4-B0DD-25C02E00B133Q36305067-F4949D35-E900-43DA-9533-4CD661AAC82EQ36404787-02B7974A-F248-41A8-8C6B-8F621A1A9F49Q36546110-B82D0BD5-AB22-4C4B-A14D-3A30D068508DQ36979305-6B1CE12D-0B2E-4BB9-A906-23516BD9C675Q37101091-60D7BA50-0219-48C4-9FEF-E7A7E85B98ABQ37640066-12E3764B-36B0-4ACF-A8B9-DE9131AA6A31Q37652234-B68358A1-323D-474B-BA1B-0036C6791E64Q38402922-4F42EF32-6C5C-454F-9B3C-EBA03E0FEEECQ39374838-8ADC69D5-141F-4CE9-99FD-B0DF8CA955C4Q40925906-E962ED9D-35BB-43AC-85C1-2EE24A911DAFQ40961271-82B90A97-BC79-461F-BDFF-F3E2EF5DB386Q41259517-DF5BE4B6-9B3E-4697-AFF0-774F6A733D0AQ41563399-6C355AC5-8C41-44B2-8A2B-A1E438692FC6Q41926477-0B6220BD-414C-4DEE-A0B0-736FC010A578Q47207817-941DC6EA-73A2-4CE1-91FF-B0C485AE15B4Q52604813-28FAD79E-3E59-4F2E-9E7A-2A642A4632F3Q58720493-8E1ADDFB-0977-414F-AB2D-BEF102E6239C
P2860
Entry, Retention, and Virological Suppression in an HIV Cohort Study in India: Description of the Cascade of Care and Implications for Reducing HIV-Related Mortality in Low- and Middle-Income Countries.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 10 July 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Entry, Retention, and Virologi ...... - and Middle-Income Countries.
@en
Entry, Retention, and Virologi ...... - and Middle-Income Countries.
@nl
type
label
Entry, Retention, and Virologi ...... - and Middle-Income Countries.
@en
Entry, Retention, and Virologi ...... - and Middle-Income Countries.
@nl
prefLabel
Entry, Retention, and Virologi ...... - and Middle-Income Countries.
@en
Entry, Retention, and Virologi ...... - and Middle-Income Countries.
@nl
P2093
P2860
P921
P356
P1476
Entry, Retention, and Virologi ...... - and Middle-Income Countries.
@en
P2093
Manoranjan Midde
Praveen Kumar Naik
Raghavakalyan Pakam
P2860
P304
P356
10.1155/2013/384805
P577
2013-07-10T00:00:00Z